350 related articles for article (PubMed ID: 33489015)
1. Exosomes derived from osteogenic tumor activate osteoclast differentiation and concurrently inhibit osteogenesis by transferring COL1A1-targeting miRNA-92a-1-5p.
Yu L; Sui B; Fan W; Lei L; Zhou L; Yang L; Diao Y; Zhang Y; Li Z; Liu J; Hao X
J Extracell Vesicles; 2021 Jan; 10(3):e12056. PubMed ID: 33489015
[TBL] [Abstract][Full Text] [Related]
2. LncRNA nuclear-enriched abundant transcript 1 shuttled by prostate cancer cells-secreted exosomes initiates osteoblastic phenotypes in the bone metastatic microenvironment via miR-205-5p/runt-related transcription factor 2/splicing factor proline- and glutamine-rich/polypyrimidine tract-binding protein 2 axis.
Mo C; Huang B; Zhuang J; Jiang S; Guo S; Mao X
Clin Transl Med; 2021 Aug; 11(8):e493. PubMed ID: 34459124
[TBL] [Abstract][Full Text] [Related]
3. miR-92a-1-5p enriched prostate cancer extracellular vesicles regulate osteoclast function via MAPK1 and FoxO1.
Yu L; Sui B; Zhang X; Liu J; Hao X; Zheng L
J Exp Clin Cancer Res; 2023 May; 42(1):109. PubMed ID: 37131239
[TBL] [Abstract][Full Text] [Related]
4. Osteoclast-derived miR-23a-5p-containing exosomes inhibit osteogenic differentiation by regulating Runx2.
Yang JX; Xie P; Li YS; Wen T; Yang XC
Cell Signal; 2020 Jun; 70():109504. PubMed ID: 31857240
[TBL] [Abstract][Full Text] [Related]
5. PC-3-Derived Exosomes Inhibit Osteoclast Differentiation by Downregulating miR-214 and Blocking NF-
Duan Y; Tan Z; Yang M; Li J; Liu C; Wang C; Zhang F; Jin Y; Wang Y; Zhu L
Biomed Res Int; 2019; 2019():8650846. PubMed ID: 31058194
[TBL] [Abstract][Full Text] [Related]
6. Liver cancer cell-secreted exosomes promote bone metastasis of liver cancer by facilitating osteoclast differentiation through the miR-574-5p/BMP2 axis.
Li T; Li M; Peng Y; Li X; Chen Y; Zhang J; Zhang Z; Zhang H; Du J
Pathol Res Pract; 2023 May; 245():154485. PubMed ID: 37120909
[TBL] [Abstract][Full Text] [Related]
7. Circ_0008542 in osteoblast exosomes promotes osteoclast-induced bone resorption through m6A methylation.
Wang W; Qiao SC; Wu XB; Sun B; Yang JG; Li X; Zhang X; Qian SJ; Gu YX; Lai HC
Cell Death Dis; 2021 Jun; 12(7):628. PubMed ID: 34145224
[TBL] [Abstract][Full Text] [Related]
8. Cancer-derived exosomal miR-375 targets DIP2C and promotes osteoblastic metastasis and prostate cancer progression by regulating the Wnt signaling pathway.
Liu Y; Yang C; Chen S; Liu W; Liang J; He S; Hui J
Cancer Gene Ther; 2023 Mar; 30(3):437-449. PubMed ID: 36434177
[TBL] [Abstract][Full Text] [Related]
9. Osteoclast-Derived Exosomal miR-5134-5p Interferes with Alveolar Bone Homeostasis by Targeting the JAK2/STAT3 Axis.
Pan L; Zhang C; Zhang H; Ke T; Bian M; Yang Y; Chen L; Tan J
Int J Nanomedicine; 2023; 18():3727-3744. PubMed ID: 37441084
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer exosomes contribute to pre-metastatic niche formation and promote bone metastasis of tumor cells.
Yuan X; Qian N; Ling S; Li Y; Sun W; Li J; Du R; Zhong G; Liu C; Yu G; Cao D; Liu Z; Wang Y; Qi Z; Yao Y; Wang F; Liu J; Hao S; Jin X; Zhao Y; Xue J; Zhao D; Gao X; Liang S; Li Y; Song J; Yu S; Li Y
Theranostics; 2021; 11(3):1429-1445. PubMed ID: 33391543
[No Abstract] [Full Text] [Related]
11. Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A.
Hashimoto K; Ochi H; Sunamura S; Kosaka N; Mabuchi Y; Fukuda T; Yao K; Kanda H; Ae K; Okawa A; Akazawa C; Ochiya T; Futakuchi M; Takeda S; Sato S
Proc Natl Acad Sci U S A; 2018 Feb; 115(9):2204-2209. PubMed ID: 29440427
[TBL] [Abstract][Full Text] [Related]
12. Exosomal miRNAs from Prostate Cancer Impair Osteoblast Function in Mice.
Furesi G; de Jesus Domingues AM; Alexopoulou D; Dahl A; Hackl M; Schmidt JR; Kalkhof S; Kurth T; Taipaleenmäki H; Conrad S; Hofbauer C; Rauner M; Hofbauer LC
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163219
[TBL] [Abstract][Full Text] [Related]
13. Small extracellular vesicles deliver osteolytic effectors and mediate cancer-induced osteolysis in bone metastatic niche.
Ma Q; Liang M; Wu Y; Dou C; Xu J; Dong S; Luo F
J Extracell Vesicles; 2021 Feb; 10(4):e12068. PubMed ID: 33659051
[TBL] [Abstract][Full Text] [Related]
14. Metastatic breast cancer cells overexpress and secrete miR-218 to regulate type I collagen deposition by osteoblasts.
Liu X; Cao M; Palomares M; Wu X; Li A; Yan W; Fong MY; Chan WC; Wang SE
Breast Cancer Res; 2018 Oct; 20(1):127. PubMed ID: 30348200
[TBL] [Abstract][Full Text] [Related]
15. Tumour-derived exosomal lncRNA-SOX2OT promotes bone metastasis of non-small cell lung cancer by targeting the miRNA-194-5p/RAC1 signalling axis in osteoclasts.
Ni J; Zhang X; Li J; Zheng Z; Zhang J; Zhao W; Liu L
Cell Death Dis; 2021 Jul; 12(7):662. PubMed ID: 34215717
[TBL] [Abstract][Full Text] [Related]
16. GATA4-driven miR-206-3p signatures control orofacial bone development by regulating osteogenic and osteoclastic activity.
Guo S; Gu J; Ma J; Xu R; Wu Q; Meng L; Liu H; Li L; Xu Y
Theranostics; 2021; 11(17):8379-8395. PubMed ID: 34373748
[TBL] [Abstract][Full Text] [Related]
17. Human bone marrow mesenchymal stem cells-derived exosomes attenuated prostate cancer progression via the miR-99b-5p/IGF1R axis.
Jiang S; Chen H; He K; Wang J
Bioengineered; 2022 Feb; 13(2):2004-2016. PubMed ID: 35030978
[TBL] [Abstract][Full Text] [Related]
18. Osteoblasts-derived exosomes regulate osteoclast differentiation through miR-503-3p/Hpse axis.
Wang Q; Shen X; Chen Y; Chen J; Li Y
Acta Histochem; 2021 Oct; 123(7):151790. PubMed ID: 34592492
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of prostate cancer osteoblastic progression with VEGF121/rGel, a single agent targeting osteoblasts, osteoclasts, and tumor neovasculature.
Mohamedali KA; Li ZG; Starbuck MW; Wan X; Yang J; Kim S; Zhang W; Rosenblum MG; Navone NM
Clin Cancer Res; 2011 Apr; 17(8):2328-38. PubMed ID: 21343372
[TBL] [Abstract][Full Text] [Related]
20. miR-99a in bone homeostasis: Regulating osteogenic lineage commitment and osteoclast differentiation.
Moura SR; Bras JP; Freitas J; Osório H; Barbosa MA; Santos SG; Almeida MI
Bone; 2020 May; 134():115303. PubMed ID: 32126314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]